SCHEMBL5154741

SCHEMBL5154741

COc1ccc2cc(C(CCC(=O)OCCSCCO)C(=O)O)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 9/20 0.54
AKR1C2 P52895 9/20 0.54
PTGS1 P23219 3/20 0.54
AKR1C1 Q04828 1/20 0.54
PTGS2 P35354 4/20 0.45
TSHR P16473 2/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45
CYP1A2 P05177 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ABCB11 O95342 1/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX5 P09917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5152798 0.89 AKR1C3 (0.61) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL219279 0.85 AKR1C3 (0.61) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL5151710 0.82 AKR1C3 (0.53) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL5151997 0.79 AKR1C3 (0.54) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL2546992 0.79 PTGS2 (0.60) AKR1C3AKR1C2PTGS1PTGS2TSHR
SCHEMBL2546993 0.79 PTGS2 (0.60) AKR1C3AKR1C2PTGS1PTGS2TSHR
SCHEMBL220609 0.79 TDP1 (0.53) AKR1C3AKR1C2PTGS1PTGS2TSHR
SCHEMBL220110 0.78 AKR1C3 (0.52) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL220415 0.77 AKR1C3 (0.67) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL220267 0.77 AKR1C3 (0.70) AKR1C3AKR1C2PTGS1AKR1C1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7163958-B2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use NITROMED INC. (US) 2007-01-16 US disclosed